Climb Bio, Inc.

CLYM · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$26$23$29$87
Short-Term Investments$61$62$69$64
Receivables$0$0$1$1
Inventory$0$0$0$0
Other Curr. Assets$4$3$1$3
Total Curr. Assets$91$87$100$155
Property Plant & Equip (Net)$1$1$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$89$103$100$62
Tax Assets$0$0$0$0
Other NC Assets$2$1$0$0
Total NC Assets$91$105$100$62
Other Assets$0$0$0$0
Total Assets$182$192$201$217
Liabilities
Payables$0$1$1$1
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4$5$6$4
Total Curr. Liab.$5$6$7$5
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$0$0
Other Liabilities$0$0$0$0
Cap. Leases$1$1$0$1
Total Liabilities$5$7$7$5
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$272-$259-$251-$230
AOCI$0$0$0$0
Other Equity$449$445$444$442
Total Equity$177$186$193$212
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$182$192$201$217
Net Debt-$25-$22-$29-$87
Climb Bio, Inc. (CLYM) Financial Statements & Key Stats | AlphaPilot